Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7054380 | 0.93 | ALDH1A1 (0.38) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL23606851 | 0.93 | ALDH1A1 (0.33) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL12777816 | 0.93 | THRB (0.32) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL17366363 | 0.91 | THRB (0.35) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL23915093 | 0.89 | THRB (0.33) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL21062490 | 0.89 | TSHR (0.35) | TSHRHPGD | |
| SCHEMBL22317191 | 0.88 | THRB (0.35) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL19071296 | 0.88 | TSHR (0.32) | THRBTSHRHPGD | |
| SCHEMBL23740281 | 0.87 | ALDH1A1 (0.31) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL15911010 | 0.87 | TSHR (0.34) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 629 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025224112-A1 | UV-CURABLE COMPOSITION FOR OPTICAL LENS BY JETTING PRINTING | ESSILOR INTERNATIONAL (FR) | 2025-10-30 | — | — | WO | claimed |
| US-12291648-B2 | Energy ray-curable resin compositions and its cured products | CANON KABUSHIKI KAISHA (JP) | 2025-05-06 | — | — | US | claimed |
| US-20210403701-A1 | CURABLE RESIN COMPOSITION, AND FILM, MOLDED ARTICLE, PREPREG, AND FIBER-REINFORCED PLASTIC USING SAID CURABLE RESIN COMPOSITION | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-12-30 | — | — | US | claimed |
| CN-106054532-A | Negative photosensitive polysiloxane composition | 台湾永光化学工业股份有限公司 | 2016-10-26 | — | — | CN | claimed |
| EP-4748893-A1 | PHOTOCURABLE RESIN COMPOSITION, ADHESIVE, SEALING MATERIAL, COATING AGENT, CURED PRODUCT, SEMICONDUCTOR DEVICE, ELECTRONIC COMPONENT, AND CURING, BONDING, SEALING, AND COATING METHODS USING PHOTOCURABLE RESIN COMPOSITION | Namics Corporation (JP) | 2026-05-27 | — | — | EP | disclosed |
| CN-122070334-A | Resin composition, sheet material, printed wiring board, and semiconductor device | 株式会社力森诺科 | 2026-05-19 | — | — | CN | disclosed |
| WO-2026100231-A1 | CURABLE RESIN COMPOSITION, ADHESIVE, SEALING MATERIAL, CURED PRODUCT, SEMICONDUCTOR DEVICE, AND ELECTRONIC COMPONENT | ナミックス株式会社 | 2026-05-15 | — | — | WO | disclosed |
| US-12625430-B2 | Colored photosensitive resin composition and mutilayer cured film prepared therefrom | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2026-05-12 | — | — | US | disclosed |
| CN-122029490-A | Photosensitive resin laminate, method for forming resist pattern, and method for forming wiring board | 旭化成株式会社 | 2026-05-12 | — | — | CN | disclosed |
| EP-3433086-B1 | ENERGETIC MATERIALS | TNO (NL) | 2026-05-06 | — | — | EP | disclosed |
| EP-4372030-B1 | CURABLE RESIN COMPOSITION | NAMICS CORP (JP) | 2026-03-25 | — | — | EP | disclosed |
| US-12583789-B2 | Composition for forming coating layer of optical fiber and cured layer thereof, optical fiber having cured layer, and use thereof | JAPAN FINE COATINGS CO., LTD. (JP) | 2026-03-24 | — | — | US | disclosed |
| US-20070146431-A1 | Ink composition, inkjet recording method, producing method of planographic printing plate, and planographic printing plate | FUJIFILM CORPORATION (JP) | 2007-06-28 | — | — | US | disclosed |
| US-20070059337-A1 | Cyclic acetal biomaterials | MARYLAND, UNIVERSITY OF | 2007-03-15 | — | — | US | disclosed |
| US-20070059337-A1 | Cyclic acetal biomaterials | MARYLAND, UNIVERSITY OF | 2007-03-15 | — | — | US | disclosed |
| EP-1722362-A1 | Magnetic recording medium | FUJI PHOTO FILM CO., LTD. (JP) | 2006-11-15 | — | — | EP | disclosed |
| US-20060093869-A1 | Magnetic recording medium | FUJI PHOTO FILM CO., LTD. | 2006-05-04 | — | — | US | disclosed |
| US-20050004318-A1 | Curable composition | OHSHIRO NOBUAKI (JP) | 2005-01-06 | — | — | US | disclosed |
| EP-1452550-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2004-09-01 | — | — | EP | disclosed |
| US-20020192601-A1 | Process for the production of film having refractive index distribution | MITSUBISHI GAS CHEMICAL COMPANY, INC. | 2002-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12625430-B2 | Colored photosensitive resin composition and mutilayer cured film prepared therefrom | RAD51, SMURF1, SMARCA1 | ALDH1A1 1348/4885TP53 2063/4885CYP3A4 4438/4885 |
| US-20070059337-A1 | Cyclic acetal biomaterials | ACMSD, EED, EHD1 | ALDH1A1 301/4885TP53 2791/4885CYP3A4 4695/4885 |
| US-12583789-B2 | Composition for forming coating layer of optical fiber and cured layer thereof, optical fiber having cured layer, and use thereof | SMC3, SMC2, SMC4 | ALDH1A1 1812/4885TP53 4640/4885CYP3A4 2686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.